The COPCOV Trial’s position statement on “A living WHO guideline on drugs to prevent COVID-19.”
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound.
Burden of soil-transmitted helminth infection in pregnant refugees and migrants on the Thailand-Myanmar border: Results from a retrospective cohort.
Brummaier T. et al, (2021), PLoS Negl Trop Dis, 15
Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations.
Tindana P. et al, (2021), Malar J, 20
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42